Our Philosophy
Our mission is to provide quality, compassionate, and innovative care to people struggling with co-occurring mental health disorders. We believe in:
- Compassionate, innovative, and quality care
- Comprehensive and individualized treatment
- Co-occurring disorder treatment
- Empowered patients, families, and communities
Crack Cocaine
Cocaine
Barbiturates
Methadone
Oxycodone
Percocet
Vicodin
chloral hydrate
Crystal Meth
Xanax
Adderall
Heroin
Xylazine
naloxone
fentanyl
oxycodone (OxyContin®)
hydrocodone (Vicodin®)
codeine
morphine
Doxorubicin “The Red Devil”
Adriamycin
Reblozyl
luspatercept
Zynteglo
betibeglogene autotemcel
Lartruvo
amphetamine (Adderall)
lisdexamfetamine (Vyvanse)
methylphenidate (Ritalin)
Concerta
Dexedrine (dextroamphetamine)
Ecstasy or Molly
Hydrocodone
Ketamine Hydrochloride
Psilocybin Mushrooms
PCP – Angel Dust
Meth (Methamphetamine)
Rohypnol (flunitrazepam)
Valium
Quaalude, or fantasy
Xelstrym
Hemgenix
Elevidys
Skysona
Zynteglo
Zolgensma
Myalept
Danyelza
Zokinvy
Kimmtrak
Luxturna
fluoxetine
selegiline
ranitidine
trazodone
nefazodone
brompheniramine
phenylpropanolamine
chlorpromazine
promethazine
ephedrine
methamphetamine
labetalol
Medications for Cancer
Other names: Carcinoma; Malignant Disease; Malignant Tumor
carboplatin
chlorambucil
Cosmegen
cyclophosphamide
dactinomycin
doxorubicin
Etopophos
etoposide
fludarabine
fluorouracil
Hycamtin
Ifex
ifosfamide
Leukeran
Tepadina
thiotepa
Toposar
topotecan
vinblastine
vincristine
Drug name | Manufacturer(s) | Indication(s) | |
|---|---|---|---|
| 1. Comirnaty COVID-19 vaccine | Pfizer/BioNTech | The COVID-19 vaccine topped the list of 2022’s 50 best-selling pharmaceuticals. It sold slightly more last year. | |
| 2. Humira (adalimumab) | AbbVie | rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis | |
| 3. Keytruda (pembrolizumab) | Merck | various cancers | |
| 4. Paxlovid | Pfizer | prevention of severe COVID-19 | |
| 5. Spikevax COVID-19 vaccine | Moderna | reduce risk of COVID-19 infection | |
| 6. Eliquis (apixaban) | Bristol Myers Squibb and Pfizer | blood clots | |
| 7. Eylea (aflibercept) | Regeneron Pharmaceuticals, Bayer | age-related macular degeneration, macular edema and diabetic retinopathy | |
| 8. Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) | Gilead Sciences | HIV | |
| 9. Revlimid (lenalidomide) | Bristol Myers Squibb (Celgene) | myelodysplastic syndrome, multiple myeloma, and mantle cell lymphoma | |
| 10. Stelara (ustekinumab) | Janssen (Johnson & Johnson) | plaque psoriasis, psoriatic arthritis, ulcerative colitis and Crohn’s disease | |
| 11. Dupixent (dupilumab) | Sanofi Genzyme, Regeneron Pharmaceuticals | atopic dermatitis, asthma, chronic rhinosinitus with nasal polyps. | |
| 12. Imbruvica (ibrutinib) | Pharmacyclics (AbbVie) and Janssen (Johnson & Johnson) | chronic lymphocytic leukemia/small lymphocytic lymphoma with 17p deletion, Waldenström’s macroglobulinemia | |
| 13. Opdivo (nivolumab) | Bristol Myers Squibb | various forms of cancer | |
| 14. Darzalex (daratumumab) | (Janssen) Johnson & Johnson | multiple myeloma | |
| 15. Trikafta/Kaftrio | Vertex Pharmaceuticals | cystic fibrosis | |
| 16. Xarelto (rivaroxaban) | Janssen (Johnson & Johnson)/Bayer | reducing risk of stroke in nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism, DVT prophylaxis following knee or hip replacement surgery | |
| 17. Trulicity (dulaglutide) | Eli Lilly | type 2 diabetes | |
| 18. Gardasil/Gardasil 9 (human papillomavirus 9-valent vaccine) | Merck | various cancers caused by human papillomavirus | |
| 19. Prevnar family (pneumococcal vaccine) | Pfizer | pneumococcal vaccine | |
| 20. Ocrevus (ocrelizumab) | Roche | relapsing or primary progressive multiple sclerosis | |
| 21. Lagevrio (molnupiravir) | Merck & Co. | oral antiviral authorized for treatment of mild to moderate COVID-19 illness | |
| 22. Tagrisso (osimertinib) | AstraZeneca | non-small-cell lung carcinomas | |
| 23. Botox (cosmetic + neuroscience) | AbbVie | cosmetic treatment of wrinkles, chronic migraine, overactive bladder, upper limb spasticity, cervical dystonia, and strabismus | |
| 24. Skyrizi (risankizumab) | AbbVie | plaque psoriasis | |
| 25. Ibrance (palbociclib) | Pfizer | HR-positive and HER2-negative breast cancer | |
| 26. Cosentyx (secukinumab) | Novartis | plaque psoriasis, psoriatic arthritis, ankylosing spondylitis | |
| 27. Entresto (sacubitril/valsartan) | Novartis | chronic heart failure and reduced ejection fraction | |
| 28. Januvia/Janumet (sitagliptin) | Merck & Co. | type 2 diabetes | |
| 29. Farxiga (dapagliflozin) | AstraZeneca | Type 2 diabetes mellitus, heart failure | |
| 30. Invega Sustenna, Xeplion, Invega Trinza/Trevicta | Janssen (Johnson & Johnson) | schizophrenia, schizoaffective disorder | |
| 31. Enbrel (etanercept) | Amgen | plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis and ankylosing spondylitis. | |
| 32. Perjeta (pertuzumab) | Roche | HER2-positive breast cancer | |
| 33. Shingrix (zoster vaccine recombinant, adjuvanted) | GSK | Vaccination against shingles | |
| 34. Hemlibra (emicizumab) | Roche | hemophilia A | |
| 35. Prolia (denosumab) | Amgen | osteoporosis, low bone mass | |
| 36. Tecentriq (atezolizumab) | Roche | urothelial carcinoma, non-small cell lung cancer and triple-negative breast cancer | |
| 37. Pomalyst/Imnovid (pomalidomide) | Bristol-Myers Squibb | multiple myeloma | |
| 38.Orencia (abatacept) | Bristol-Myers Squibb | rheumatoid arthritis, juvenile idiopathic arthritis | |
| 39. Lynparza (olaparib) | AstraZeneca/Merck & Co. | Ovarian cancer, breast cancer | |
| 40. Imfinzi (durvalumab) | AstraZeneca | Various oncology indications | |
| 41. Tremfya (guselkumab) | Janssen (Johnson & Johnson) | moderate to severe plaque psoriasis | |
| 42. Actemra/RoActemra (tocilizumab) | Roche | rheumatoid arthritis, forms of juvenile idiopathic arthritis and giant cell arteritis as well as CAR T cell-induced severe or life-threatening cytokine release syndrome | |
| 43. Symbicort (budesonide formoterol) | AstraZeneca | asthma, airflow obstruction in patients with COPD | |
| 44. Rinvoq (upadacitinib) | AbbVie | moderate to severe rheumatoid arthritis in adult patients who have had an inadequate response to methotrexate | |
| 45. Verzenio (abemaciclib) | Eli Lilly | HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant | |
| 46. Taltz (ixekizumab) | Eli Lilly | moderate to severe plaque psoriasis in adults, active psoriatic arthritis, active ankylosing spondylitis, and active non-radiographic axial spondyloarthritis | |
| 47. Vyndaqel (tafamidis) | Pfizer | treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adult patients to reduce cardiovascular mortality and cardiovascular-related hospitalization | |
| 48. Genvoya (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) | Gilead Sciences | HIV-1 infection | |
| 49. Lantus (insulin glargine) | Sanofi | diabetes | |
| 50. Remicade (infliximab) | Janssen (Johnson & Johnson) | Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis |